Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 17, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

[Mixed lung tumors: pathological update].

Isabelle Rouquette1

  • 1CHU Rangueil, service d'anatomie pathologique et histologie cytologie, Toulouse cedex, France. rouquette.i@chu-toulouse.fr

Bulletin Du Cancer
|November 3, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usefulness of an RNA extraction-free test for the multiplexed detection of <i>ALK</i>, <i>ROS1</i>, and <i>RET</i> Gene Fusions in Real Life FFPE Specimens of Non-Small Cell Lung Cancers.

Expert review of molecular diagnostics·2023
Same author

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.

Nature genetics·2023
Same author

Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by <i>KRAS</i> Mutation Subtypes.

JTO clinical and research reports·2021
Same author

Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC study.

Virchows Archiv : an international journal of pathology·2021
Same author

[Thymoma and squamous thymic carcinoma diagnosis; experience from the RYTHMIC network].

Annales de pathologie·2020
Same author

Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study.

European journal of cancer (Oxford, England : 1990)·2020
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
See all related articles

Accurate pathological diagnosis of rare lung tumors is crucial for effective treatment. Advanced techniques like immuno-histochemistry and multidisciplinary classifications refine diagnoses, enabling targeted therapies for molecular anomalies.

Area of Science:

  • Pathology
  • Oncology
  • Molecular Biology

Context:

  • Lung cancer diagnosis relies on the World Health Organization (WHO) classification (2004).
  • Rare tumors with multiple tumoral components present diagnostic and therapeutic challenges.
  • Refining diagnoses is essential for appropriate patient management.

Purpose:

  • To highlight the importance of precise pathological diagnosis in complex lung cancer cases.
  • To introduce advanced diagnostic methods for challenging tumor types.
  • To underscore the link between accurate diagnosis and targeted therapy eligibility.

Summary:

  • Pathological diagnosis of lung cancer, based on the WHO 2004 classification, faces challenges with rare tumors containing multiple tumoral contingents.
  • Immuno-histochemistry and the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification refine diagnoses from biopsies.

Related Experiment Videos

Last Updated: May 17, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

  • Accurate pathological diagnosis is essential as some tumors exhibit molecular anomalies, making them candidates for precision medicine and targeted therapies.

    • Impact:

    • Improved diagnostic accuracy for rare lung tumors.
    • Enhanced selection of patients for targeted therapies.
    • Better therapeutic coverage and patient outcomes in lung cancer management.